USPTO serial 79188417
NANOMEDTALKS
Reviewed by CopyMark Law Group
Reg. 5202213Status 404
- Filing date
- Status date
- Registration date
- May 16, 2017
- Examiner
- CROWLEY, SEAN MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NANOMEDTALKS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business information; business investigations | SECTION 71 - CANCELLED | — |
| 041 | Educational services, namely, providing classes, seminars, workshops, continuing professional education courses, presentations and retreats in the field of medicine, nanomedicine, technology, nanotechnology and innovation; medical training services; organization and conducting of educational conferences in the fields of medicine, nanomedicine, technology, nanotechnology and innovation; organization and conducting of educational congresses in the fields of medicine, nanomedicine, technology, nanotechnology and innovation; organization and conducting of seminars in the fields of medicine, nanomedicine, technology, nanotechnology and innovation; organization and production of television shows; presentation of live show performances; publication of magazines, books and manuals in the field of medicine; conducting of training courses in the field of technology and innovation | SECTION 71 - CANCELLED | — |
| 042 | Scientific research particularly in the field of nanomedicine, nanotechnology applied to medicine; technological consulting services particularly in the field of nanomedicine, nanotechnology applied to medicine; evaluations and assessments in the nature of research in the field of nanoscience and nanotechnology, particularly applied to medicine; consulting in the field of engineering in the nature of preparation of reports relating to research in nanoscience and nanotechnology; provision of information regarding medical nanotechnology | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nanobiotix,
- Other trademarks owned by Nanobiotix,
- Other trademarks owned by Nanobiotix,
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named NANOMEDTALKS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 22, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 24, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 8, 2024 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 8, 2024 | INPC | INVALIDATION PROCESSED | — |
| Aug 2, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 1, 2023 | C71T | CANCELLED SECTION 71 | — |
| Sep 29, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 17, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 17, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 16, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 16, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 28, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 24, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 8, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 8, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 8, 2017 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 26, 2017 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jan 26, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 26, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 26, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 30, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 30, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 30, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 5, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 21, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 21, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 21, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 20, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 12, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 8, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 7, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |